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Abstract 
As substance use increases in the United States, the number of neonates born with 
neonatal abstinence syndrome (NAS) has also increased from women using substances during 
pregnancy.  Consequently, the healthcare industry has noticed a significant rise in the number of 
neonates born with NAS withdrawal symptoms, increasing healthcare costs and need for 
evidence-based practice.  The purpose of this systematic review is to appraise the evidence 
regarding the effects of supplemental nonpharmacological interventions, specifically 
breastfeeding and rooming-in, compared to standard pharmacological treatment, on outcomes in 
neonates with NAS.  Twenty peer-reviewed research studies conducted between 2010 and 2018 
were obtained from scholarly databases. Studies were analyzed based on relevance to neonates 
experiencing NAS symptoms and nonpharmacological interventions of breastfeeding and 
rooming-in.  Researchers consistently concluded that breastfeeding and rooming-in positively 
impact NAS outcomes by decreasing the need for pharmacological treatment, severity of NAS 
withdrawal symptoms, and length of stay.   
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Effects of Nonpharmacological Interventions on Outcomes in Neonates with Neonatal 
Abstinence Syndrome: A Systematic Review 
The United States is falling deeper into the midst of an intensifying opioid epidemic as 
evidenced by 42,000 deaths from opioid overdoses in 2016, which is five times the number of 
deaths in 1999 (Centers for Disease Control and Prevention [CDC], 2018). Women of 
childbearing age constitute a large portion of those suffering from opioid use. In fact, nearly one-
third of those people being treated for opioid addiction are women of the childbearing age 
(O’Connor, Collett, Alto, & O’Brien, 2013).  This is a significant problem because 21,732 
neonates in 2012 were born with opiate withdrawal symptoms; therefore, an addicted neonate is 
born every 25 minutes (National Institute on Drug Abuse, 2015). 
Substance abuse during pregnancy leads to the development of neonatal abstinence 
syndrome (NAS) in neonates.  NAS is classified as the possible withdrawal syndrome that 
neonates may experience due to in-utero exposure to opioids and is “characterized by 
hyperirritability of the central nervous, the gastrointestinal, the respiratory and the autonomic 
nervous systems” (Welle-Strand et al., 2013, p. 1060).  Various consequences affecting addicted 
mothers and neonates include but are not limited to: intrauterine growth restriction, preterm 
rupture of membranes, placental insufficiency, premature birth, postpartum hemorrhage, and 
potentially perinatal mortality (O’Connor et al., 2013).  These perinatal and postpartum 
complications lead to high-risk pregnancies and postpartum periods, causing detrimental effects 
on neonates and mothers.  Neonates at risk for NAS are carefully monitored for signs and 
symptoms of withdrawal.  The effects of NAS in the immediate postpartum period include 
increased chance of disrupted mother-neonate bonding, sleeping and feeding difficulties, weight 
loss, and seizures (Bhatt-Mehta, Ng, & Schumacher, 2014).  These problems often make the 
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neonatal transition difficult and may result in admission to neonatal intensive care units (NICU) 
(McKnight et al., 2016).   
Moreover, the rise in neonates with NAS has consequences for the healthcare industry, 
increasing length of hospital stays and costs.  With increased NAS incidence and treatment, the 
costs of care per neonate rose 30% to approximately $69,000, from 2009 to 2012, resulting in 
$1.5 billion in additional hospital charges overall (Crook & Brandon, 2017).  Furthermore, as 
many as 50% of neonates with NAS are sent to NICUs, consequently diminishing available beds 
for neonates experiencing other indispositions (Loudin et al., 2017).  Newborns with NAS 
symptoms are often treated in NICUs to ensure neonatal well-being and symptom management 
(Holmes et al., 2016).  When neonates are admitted to NICUs, costs per case can be as high as 
$93,000 compared to $20,000 for standard neonatal care (Howard et al., 2017).  Additionally, 
less costly nonpharmacological interventions are difficult to implement when neonates are 
treated in NICUs due to the mother-neonate separation. 
Within the first postnatal days, neonates exposed to opioids in utero begin to express 
withdrawal symptoms; thus, further action is needed to avoid major complications (Hünseler, 
Brückle, Roth, & Kribs, 2013).  Withdrawal symptoms in neonates are quantified using the 
Finnegan scale, which is a systematic method of scoring 21 signs that grade neonatal withdrawal 
severity (Timpson, Killoran, Maranda, Picarillo, & Bloch-Salisbury, 2018).  The Finnegan 
Scoring System measures central nervous system symptoms, such as high-pitched crying, ease of 
feeding, muscle tone, and temperature (McQueen, Murphy-Oikonen, Gerlach, & Montelpare, 
2011).  Nurses subjectively rate each sign with a numerical value from one to three, based on the 
severity of the symptoms, and these values are added together for a total score.  Three 
consecutive scores greater than or equal to eight are indicative of NAS (O’Connor et al., 2013).    
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Regarding the need for pharmacological treatment to relieve NAS symptoms, over half of 
neonates exposed to opioids need such pharmacological intervention (Howard et al., 2017).  The 
first-line treatment for neonates expressing symptoms of NAS includes opiates, such as 
methadone and buprenorphine (Hünseler et al., 2013).  Methadone therapy is begun if neonates 
score higher than eight on two consecutive occasions when using the Finnegan scale (Isemann, 
Meinzen-Derr, & Akinbi, 2011).  The pharmacological treatment of NAS with methadone may 
cause hypertonicity, irritability, and disorganized sucking, further complicating neonates’ 
withdrawal symptoms and breastfeeding (Demirci, Bogen, & Klionsky, 2015).  If neonates reach 
maximum dosage of methadone and continue displaying signs of NAS withdrawal, phenobarbital 
can be used as a second-line therapy (Howard et al., 2017).  Eventually, pharmacological 
treatment is weaned to the lowest dose and discontinued.  Before neonates are discharged home, 
they are monitored for 24 to 48 hours following completion of opioid replacement therapy 
(Howard et al., 2017).  Consequently, the use of pharmacologic therapy increases the length of 
stay (LOS) in neonates with NAS. 
Nurses may supplement treatment with nonpharmacological interventions, such as 
breastfeeding and rooming-in, which have been found to promote bonding and attachment in 
neonates and to decrease the severity of withdrawal symptoms (Newman et al., 2015; Pritham, 
Paul, & Hayes, 2012).  Benefits of these nurse-driven interventions include decreased costs and 
fewer side effects.  The purpose of this systematic review is to identify and critically appraise the 
evidence regarding effects of supplemental nonpharmacological interventions, specifically 
breastfeeding and rooming-in, compared to standard pharmacological treatment, on outcomes in 
neonates with NAS withdrawal symptoms.  This systematic review will answer the following 
PICOT question: In neonates exposed to opioids in utero, how do supplemental 
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nonpharmacological interventions, compared to standard pharmacological treatment alone, affect 
neonatal outcomes directly after birth through discharge from the hospital?  This systematic 
review is significant to nurses because, with an increased number of pregnant women abusing 
opioids, nurses have seen a fivefold increase in neonates expressing signs and symptoms of NAS 
within the past 15 years (Schiff et al., 2018).  Since pharmacotherapy is associated with side 
effects and complications, nurses need to promote positive outcomes for neonates with NAS by 
enhancing practice. This should be based on evidence regarding the effectiveness of nurse-
initiated, nonpharmacological interventions.  
Methods 
The goal of the search was to identify studies that met inclusion criteria, specifically 
where nonpharmacological treatment was provided and compared to standard care of neonates 
with NAS.  Common nonpharmacological interventions identified by the search were 
breastfeeding and rooming-in, which consequently promote bonding and attachment in the early 
phase of the NAS-affected neonates’ lives (Newman et al., 2015; Pritham et al., 2012).  The 
desired time period of outcomes was from the birth of the neonates to discharge from the 
hospital.  The studies were published between 2010 and 2018 and were found in the following 
databases: CINAHL Plus with Full Text, MEDLINEPlus, PSYCHInfo, and SOCIndex. 
After identifying pertinent nonpharmacological interventions, keywords included 
neonatal abstinence syndrome, NAS, withdrawal, breastfeeding, rooming-in, and opioid 
treatment.  A search with keywords of ‘neonatal abstinence syndrome or NAS or withdrawal’ 
and ‘breastfeeding or rooming-in’ resulted in 499 articles.  ‘Neonatal abstinence syndrome’ and 
‘breastfeeding’ and ‘opioid treatment’ yielded 20 publications.  ‘NAS or neonatal abstinence 
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syndrome’ and ‘breastfeeding’ produced 5,002 publications.  In addition, ‘NAS or neonatal 
abstinence syndrome’ and ‘rooming-in’ produced 7,109 publications.  
Additionally, the US National Library of Medicine’s PubMed Central (PMC) database 
was searched.  Keywords of ‘neonatal abstinence syndrome’ and ‘breastfeeding’ and ‘opioid 
maintenance treatment’ produced 83 results.  Lastly, Google Scholar databases were searched 
with keywords of ‘rooming-in’ and ‘neonatal abstinence syndrome’, yielding 856 results, and 
with ‘neonatal abstinence syndrome’ and ‘breastfeeding’ and ‘rooming-in’, resulting in 624 
results.  
At the beginning of the searching procedure, publications that were older than five years 
were excluded using advanced search methods within the databases.  Since retrieved publications 
were limited in number within this time frame, criteria were extended to eight years.  This 
allowed for identification of more publications relevant to and answering the PICOT 
question.  Exclusion criteria included secondary sources, literature reviews, or meta-analyses; 
therefore, only primary sources were included in the review.  Publications were selected without 
bias to show variation and inconsistencies that were present in findings.   
Throughout the searches, many publications were carefully reviewed to determine if they 
answered the PICOT question and discussed the impact of breastfeeding and rooming-in 
compared with standard care of neonates with NAS.  This was done by first analyzing the title of 
each article and then, if applied to the research question, content was read for relevancy.  After a 
comprehensive review of all major relevant research, a total of 20 studies were included in this 
systematic review.  
Review of Literature 
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The 20 studies obtained for this systematic review were carefully read to determine their 
relevance to NAS symptoms and nonpharmacological interventions of breastfeeding and 
rooming-in.  The setting of the studies ranged from locations as close as Cincinnati, Ohio to as 
far as Western Sydney and Norway.  The most commonly used design was a comparison cohort, 
generating level four evidence.  In all but one study, researchers reviewed the medical records of 
mothers and neonates who met inclusion and exclusion criteria and compared neonates who 
received standard care to those who roomed-in with their mothers or were breastfed.  In the study 
that was the exception, researchers collected data with questionnaires from mothers who were 
invited to participate in the study.  Because many of these studies were performed by examining 
medical records, prior documentation may not have been an accurate representation of the care 
that was provided.  Unlike consistent sampling and data collection methods across studies, 
sample sizes varied greatly from only 11 up to 3,725 participants.  This may limit researchers’ 
findings since small sample sizes are not as representative of the entire population.  In the 
following sections, breastfeeding interventions and outcomes in neonates with NAS will be 
initially presented, followed by rooming-in interventions and outcomes in this 
population.  Intervention outcomes include pharmacological use, NAS symptoms and scores, and 
LOS.  
Breastfeeding  
One major nonpharmacological intervention used to affect outcomes in neonates with 
NAS is breastfeeding.  Newborns’ optimal nutrition is maternal milk, and in general, 
breastfeeding has positive impact on both the mothers’ and neonates’ health, as well as early 
bonding and attachment (Welle-Strand et al., 2013).  Additionally, the severity of NAS 
symptoms are mitigated as maternal opioids are transferred in the breast milk (Demirci et al., 
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2015).  The women included in these studies met certain requirements in order to breastfeed their 
neonates (Schiff et al., 2018).  For example, contraindications to breastfeeding included illicit 
drug use, HIV, herpes lesions on the breasts, hepatitis C with nipples that are cracked and 
bleeding, or other prescription medications that are transmitted through the breastmilk and 
harmful to the neonates (Short, Gannon, & Abatemarco, 2016).  
Across the 20 studies, researchers specified findings related to breastfeeding and how it 
can affect neonates exhibiting NAS.  For example, researchers in six studies found that 
breastfeeding can decrease the need for pharmacological treatment (Grossman et al., 2017; 
Hodgson & Abrahams, 2012; Liu, Juarez, Nair, & Nanan, 2015; O’Connor et al., 2013; Welle-
Strand et al., 2013; Yonke, Maston, Weitzen, & Leeman, 2018).  Researchers in five studies also 
found that breastfeeding reduced NAS scores and symptoms of neonates (Demirci et al., 2015; 
Liu et al., 2015; McQueen et al., 2011; O’Connor et al., 2013; Welle-Strand et al., 2013).  Lastly, 
researchers of seven studies supported that breastfeeding can lead to a decreased average length 
of stay in neonates with NAS (Crook & Brandon, 2017; Grossman et al., 2017; Isemann et al., 
2011; Pritham et al., 2012; Schiff et al., 2018; Short et al., 2016; Well-Strand et al., 2013).   
Pharmacological therapy.  Several researchers have found that breastfeeding diminishes 
the need for pharmacological therapy with reductions ranging from 84% to 6.9% (Grossman et 
al., 2017;Hodgson & Abrahams, 2012; Liu et al., 2015; O’Connor et al., 2013; Welle-Strand et 
al., 2013; Yonke et al., 2018).  In the study conducted by Yonke et al. (2018) of 228 neonates, 
the percentage of neonates that were breastfed and required pharmacological intervention 
decreased by 31.6% compared to the formula fed group.  Similarly, in a study of 194 mother-
neonate dyads, Liu et al. (2015) found that by adhering mostly to breastfeeding during the early 
postpartum period, NAS pharmacological treatment decreased by 37%.  However, Welle-Strand 
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et al. (2013) studied 124 neonates and concluded that only a 12% decreased need for 
pharmacological treatment was associated with breastfed neonates versus non-breastfed 
neonates.  Additionally, O’Connor et al. (2013) studied 85 maternal-neonate pairs and found a 
6.9% decreased need for pharmacotherapy.  
NAS scores and symptoms.  Researchers have consistently found that breastfeeding 
delays the onset of NAS symptoms, lessens severity of symptoms, and overall decreases mean 
NAS scores (Demirci et al., 2015; Liu et al., 2015; McQueen et al., 2011; O’Connor et al., 2013; 
Welle-Strand et al., 2013).  Several researchers examined the effects of breastfeeding in relation 
to NAS scores.  McQueen et al. (2011) used a modified Finnegan Scoring System and found that 
breastfeeding reduced the Finnegan mean score in 28 neonates; the mean peak score of the 
breastfed group was 4.9 versus formula-fed of 6.9.  On the other hand, O’Connor et al. (2013) 
discovered that of 85 neonates, the breastfed group in their study had a mean Finnegan peak 
score of 8.83 versus 9.65 in the formula-fed group.  Both research groups found that a score of 
eight or above was less likely to occur in those neonates who were breastfed; thus, 
pharmacological treatment with buprenorphine or methadone was not required (McQueen et al., 
2011; O’Connor et al., 2013).  McQueen et al. (2011) found that 40.2% of formula-fed neonates 
scored higher than eight on the Finnegan scale requiring pharmacological therapy, compared to 
only 17% of breastfed neonates.  NAS withdrawal scoring is subjective, which suggests that 
Finnegan totals will vary based on the healthcare professional performing the assessment.  This 
identifies a limitation that must be considered when analyzing the relationships between NAS 
scores and nonpharmacological intervention implementation. 
Length of stay.  Hospital LOS is another outcome of breastfeeding in neonates with 
NAS (Crook & Brandon, 2017; Grossman et al., 2017; Isemann et al., 2011; Pritham et al., 2012; 
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Schiff et al., 2018; Short et al., 2016; Welle-Strand et al., 2013).  Differences in LOS for 
breastfed neonates with NAS and those not breastfed ranged from 16.5 days to 2.78 days.  In a 
study of 287 neonates, Grossman et al. (2017) discovered that the average LOS decreased from 
22.4 to 5.9 days when breastfeeding was implemented, which was a 74% reduction.  
Additionally, the average LOS of 200 neonates who were only pharmacologically treated was 
12.74 days longer than those who were breastfed (Crook & Brandon, 2017).  However, in 
contrast, Isemann et al. (2011) and Schiff et al. (2018) both discovered a three-day decrease in 
LOS with sample sizes of 128 and 564 respectively, when breastfeeding was implemented.  
Crook & Brandon (2017) also found that neonates solely breastfed had a 2.78-day shorter LOS 
compared to those who received more than 50% human milk during hospitalization.   
In the process of compiling research, hospital readmission was identified as a gap in 
knowledge.  Neonates were analyzed until hospital discharge; consequently, information on 
whether or not neonates were readmitted to the hospital for further treatment was not available. 
This is due to the collection method utilized in the studies, which limited data to the initial 
hospital stay.  
Rooming-In  
Another method shown to improve outcomes in neonates with NAS is rooming-in, which 
prevents separation of mothers and neonates during the critical time after birth and promotes 
effective bonding and attachment (Newman et al., 2015).  Howard et al. (2017) described 
rooming-in as allowing neonates to stay in the same room as their mothers during 
hospitalization.  Neonates who room-in require less pharmacological therapy, experience less 
severe signs of NAS, and have decreased hospital LOS (Newman et al., 2015).  In general, 
researchers have concluded that rooming-in positively affects neonates with NAS.  
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Of the 20 studies in this systematic review, a majority discussed the impact of rooming-in 
on neonates experiencing NAS symptoms.  Researchers in seven studies clarified outcomes of 
rooming-in with the need for pharmacological treatment (Hodgson & Abrahams, 2012; Holmes 
et al., 2016; Howard et al., 2017; Hünseler et al., 2013; McKnight et al., 2016; Newman et al., 
2015; Saiki, Lee, Hannam, & Greenough, 2010).  Researchers of two studies described the 
effects of rooming-in on the severity of NAS scores and symptoms (Howard et al., 2017; 
Hodgson & Abrahams, 2012).  Researchers of eight studies also examined the effects of 
rooming-in implementation on related hospital LOS (Abrahams et al., 2010; Grossman et al., 
2017; Holmes et al., 2016; Howard et al., 2017; Hünseler et al., 2013; McKnight et al., 2016; 
Newman et al., 2015; Saiki et al., 2010).   
Pharmacological therapy.  Researchers have consistently reported that rooming-in 
decreases the need for pharmacological treatment with methadone and buprenorphine (Holmes et 
al., 2016; Howard et al., 2017; Hünsler et al., 2013; McKnight et al., 2016; Newman et al., 2015; 
Saiki et al., 2010).  The percentage of neonates requiring pharmacological treatment decreased, 
ranging from 9% to 69% when rooming-in was implemented (Holmes et al., 2016; Hünsler et al., 
2013; McKnight et al., 2016; Newman et al., 2015; Saiki et al., 2010).  Hünsler et al. (2013) and 
Howard et al. (2017) found that rooming-in and maternal involvement reduced the need for 
pharmacological therapy by 17% and 19% respectively, with sample sizes of 77 and 86 
neonates.  Additionally, researchers have examined other factors related to rooming-in that may 
contribute to reduced need for pharmacotherapy.  For example, Hünseler et al. (2013) found that 
the increased mother-baby contact associated with rooming-in, such as cuddling and swaddling, 
contributed to decreased need for pharmacological intervention.  Also, because the postpartum 
units are typically quieter than the neonatal units, the difference in environments could also 
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influence the reduced need for pharmacotherapy (Saiki et al., 2010).  The effectiveness of 
rooming-in on pharmacological therapy may not be as accurate because, as stated above, other 
factors such as swaddling and skin-to-skin contact occur simultaneously.  
NAS scores and symptoms.  Rooming-in has decreased Finnegan peak NAS scores and 
has also been observed to decrease the severity of withdrawal symptoms in neonates suffering 
with NAS symptoms (Hodgson & Abrahams, 2012; Howard et al., 2017).  In a sample of 86 
neonates, Howard et al. (2017) reported that average Finnegan NAS scores of roomed-in 
neonates with increased maternal presence were significantly lower compared with those not 
roomed-in, and the average NAS score was decreased by one point on the Finnegan scale 
following 100% maternal presence.  Similarly, according to Hodgson & Abrahams (2012), 295 
neonates who were allowed to room-in with their mothers had a decreased rate of developing 
NAS symptoms, and if the symptoms did develop, the need for treatment was reduced compared 
to their non-breastfed counterparts.  
Length of stay.  Length of hospital stay in neonates with NAS is crucial, as extended 
NICU stays are detrimental to early bonding efforts and family interactions (Abrahams et al., 
2010).  Many researchers explored the effects of rooming-in on neonatal LOS and found 
reductions ranging from 3.9 to 19 days (Grossman et al., 2017; Holmes et al., 2016; Howard et 
al., 2017; Hünseler et al., 2013; McKnight et al., 2016; Newman et al., 2015; Saiki et al., 2010).   
In a study conducted by Newman et al. (2015) to identify the effects of rooming-in on a sample 
of 21 neonates, the LOS decreased from approximately 25 to 8 days when rooming-in was 
implemented.  Furthermore, reductions from 16.9 to 12.3 days were reported by Holmes et al. 
(2016) in a study of 163 neonates.  Additionally, a nine-day decrease in average LOS was noted 
by Howard et al. (2017) when rooming-in was completed.  These researchers discovered reduced 
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LOS from rooming-in; however, Abrahams et al. (2010) found a ten-day increase in LOS from 
NICU standard care to rooming-in.  In this study, both neonates and mothers had longer stays; 
the rooming-in LOS was 21 days and the standard care was 11 days.  Based on findings in other 
studies, it is unknown what factors caused this increased LOS.  
Critical Appraisal of the Evidence 
Limitations of Findings 
Throughout this systematic review of the literature, breastfeeding and rooming-in were 
analyzed to determine the effects on neonatal outcomes.  Limitations include the Finnegan 
Scoring System of NAS symptoms, pharmacological need with rooming-in, polysubstance abuse 
and underreporting of maternal drug use, and factors influencing LOS.  
First, a major limitation is the method by which the neonates’ symptoms are scored.  
Some facilities implemented the Finnegan Scoring System while others used a modified system 
focusing on fewer neonatal outcomes.  However, even if the same Finnegan scale was used 
across studies, the results would still be inconsistent because of the system’s subjectivity.  For 
example, if a neonate is experiencing tremors, one nurse may think that they are mild and rate 
them accordingly; however, another nurse could think they were quite significant, rating them 
much differently.  
 Another limitation of findings is related to the effects of rooming-in on the need for 
pharmacological therapy.  Rooming-in is difficult to be measured independently because other 
factors are involved when rooming-in takes place.  For instance, if the neonate is in the same 
room as the mother, higher incidences of swaddling and skin-to-skin contact will most likely 
occur compared to neonates who reside in the nursery.  Therefore, it is hard to determine whether 
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the actual rooming-in was beneficial, or if mother-neonate contact was correlated to differences 
in pharmacological needs. 
 Maternal drug use is unclear due to the large variability as well as self-reporting of drug 
use by the mothers included in the studies.  Many studies concluded that drug use during 
pregnancy was often underreported and some mothers used multiple drugs simultaneously, 
ultimately leading to inaccurate data and different symptom presentation in neonates after birth 
(Bhatt-Mehta et al., 2014; Liu et al., 2015; McKnight et al., 2016; O’Connor et al., 2013; Pritham 
et al., 2012).  
 Additionally, it was not possible to accurately determine factors influencing neonatal 
LOS.  In some of the studies, rooming-in and breastfeeding decreased the LOS (Grossman et al., 
2017; Holmes et al., 2016; Howard et al., 2017; Hünseler et al., 2013; McKnight et al., 2016; 
Newman et al., 2015; Saiki et al., 2010); however, in one study, the LOS was considerably 
greater in the rooming-in group compared to those who received standard care (Abrahams et al., 
2010).  As a result, other factors may have influenced this change that were not specified in the 
studies. Plus, due to the data collection method focusing only on neonates’ initial hospital stay, 
data on readmission for further treatment was limited.  
Validity and Reliability of Methods 
In the studies for this systematic review, validity and reliability varied.  Nearly all the 
studies were retrospective, which posed questions regarding the validity of the reports; 
retrospective studies rely on past information that was documented, which could be interpreted 
incorrectly.  Additionally, retrospective studies lack randomization since inclusion criteria is 
determined by the researchers.   
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Reliability is another issue that must be considered to determine whether the findings are 
accurate.  In many of the studies, maternal drug use was self-reported, which could have led to 
underreporting and data alteration.  Furthermore, studies with larger sample sizes are more 
reliable, decreasing the margin of error and increasing generalizability (Demirici et al., 2015).  
Another factor contributing to decreased reliability is the NAS symptom scoring tools which 
were different across the studies.  Several studies used the Finnegan Scoring System (Grossman 
et al., 2017; Howard et al., 2017; Hunseler et al., 2013; Isemann et al., 2011; Liu et al., 2015; 
Newman et al., 2015; O’Connor et al., 2013) where others used a modified Finnegan Scoring 
System (Holmes et al., 2016; McKnight et al., 2016; McQueen et al., 2011) or other methods 
(Demirci et al., 2015; Short et., 2016; Welle-Strand et al., 2013).  
Limitations Across Studies 
Across studies, there were limitations identified that may have impacted the study 
processes.  An important limitation is small sample sizes, which can prevent accurate results.  
Throughout the process of identifying articles for the systematic review, there was a limited 
number of available studies published within five years.  Therefore, search criteria were 
extended to eight years to allow for identification of additional research. 
Maternal situations should also be analyzed as the methods of study may have prevented 
certain outcomes and interventions.  If a randomized method was used, mothers would have been 
told whether or not to breastfeed, which would be unethical.  Additionally, some of the mothers 
were not able to breastfeed due to illicit drug use, HIV, herpes lesions on the breasts, hepatitis C 
with nipples that are cracked and bleeding, or other prescription medications (Short et al., 2016).  
Lastly, some studies did not list whether the mothers had used methadone, buprenorphine, or 
another medication-assisted treatment, which could have altered results.   
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Synthesis of the Evidence 
 From this systematic review, evidence was critically appraised to determine the current 
state of science.  The results of the literature review all pointed to the positive effects of 
rooming-in and breastfeeding, except for one article (Abrahams et al., 2010).  Due to the 
consistency of the findings, these studies are an accurate representation of current interventions 
that can be used to promote positive effects in neonates with NAS.  
Recommendations 
After an extensive review of research, potential practice and research implications for 
future studies were determined.  Many of these studies proved that breastfeeding and rooming-in 
methods of nonpharmacological treatment have been efficient in reducing the need for 
pharmacological treatment, decreasing the overall length of stay, and minimizing the NAS signs 
and symptoms displayed by neonates.  Therefore, breastfeeding and rooming-in should be 
recommended and encouraged by all healthcare professionals.  
 First, it is recommended that a standard screening process should be developed for 
neonates who are at risk of developing NAS and mothers who have a history of substance abuse.  
In addition to this screening process, mothers should be encouraged to take part in an educational 
program to teach them the benefits of prenatal preventative measures rather than reactive 
measures requiring symptom management after birth.  These mothers should also be educated on 
the benefits of nonpharmacological measures such as breastfeeding and rooming-in and the 
positive impact they have on neonatal outcomes.  Extra support and education may be needed for 
these high-risk mothers that encounter stigmatization due to their substance abuse.  From this, it 
is important that medical treatment, resources, and classroom teaching should be made readily 
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available throughout the community or in local hospitals to increase the incidence of mothers 
who stop or decrease the abuse of illicit substances.  
Another recommendation is to create an atmosphere within the hospital that encourages 
rooming-in for neonates showing signs of withdrawal.  Nurses and doctors on the postpartum 
floors should be given special education on caring for neonates who are experiencing NAS 
withdrawal symptoms so they can provide appropriate care.  Furthermore, implementation of a 
standardized scoring method, such as a modified or improved Finnegan system, should be 
considered to determine when symptoms are too severe that neonates can no longer be treated on 
a normal postpartum floor.  This may help to alleviate overcrowded NICUs, especially as 
neonates with NAS are becoming more prevalent with a rise in drug abuse.   
Future studies that could advance nursing practice in this area should be focused on 
identifying childbearing women’s preconceived beliefs about breastfeeding and addressing these 
fears and factors that inhibit its practice.  Future studies should be done to determine why women 
choose not to breastfeed and to identify specific factors that prevent them from continuing 
breastfeeding outside of the hospital setting.  Healthcare providers need to address these factors 
to increase breastfeeding in this at-risk population in order to decrease NAS withdrawal in  
neonates.  In addition, healthcare providers need to stress the importance and impact that 
breastfeeding can have on NAS withdrawal severity to mothers during prenatal visits.  Because it 
has been concluded that breastfeeding prevalence is higher in women who room-in with their 
neonates, future studies should include a statistical examination of the relationship between 
rooming-in and breastfeeding rates.  Additionally, at-risk mothers may also need extra support 
and guidance to help initiate the breastfeeding process; therefore, a lactation consultant may be 
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effective in assisting and educating the mother, as well as providing encouragement to continue 
breastfeeding.  
In regard to the research design, future studies should collect data prospectively rather 
than retrospectively.  Additionally, studies should have larger sample sizes to prove their 
reliability and to make larger conclusions about the populations being studied.  Regarding the 
signs and symptoms of NAS, studies should not solely focus on the neonatal period but should 
extend criteria in order to follow the child through the developmental process.  A longer study 
period would have benefits of identifying how NAS affects its subjects later in life related to 
growth and mental capabilities.   
Conclusion 
 Breastfeeding and rooming-in are beneficial for neonates who are experiencing 
symptoms of NAS.  From the studies analyzed in this systematic review, many positive 
outcomes were measured as a result of breastfeeding and rooming-in implementation such as 
decreased use of pharmacological therapy, NAS scores and symptoms, and LOS.  However, 
there are many additional factors that need to be identified and quantified in future studies as 
well as interventions and programs that can be implemented to decrease NAS prevalence in 
childbearing mothers who abuse substances.  
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through the 
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explain the benefits 
of breastfeeding 
with regards to NAS 
withdrawal 
symptoms. This 
group is especially 
at risk for negative 
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breastfeeding due to 
their substance 
abuse. 
This was a convenience 
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study. 
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Roth, & Kribs, 
2013, p. 247) 
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of delivery was not 
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collection of medical 
records could alter the 
results of the study. 
Finnegan scoring is a 
subjective assessment 
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was a retrospective study.  
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There was a small sample 
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fed with expressed breast 
milk in this study due to 
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retrospective as 
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